Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumours: A Scientometric Analysis

The purpose of this scientometric analysis is to explore the global research landscape for Peptide Receptor Radionuclide Therapy (PRRT) using 7608 records gathered between 2000 and 2025. The study demonstrates a steady rise in publication output, with a notable increase in the recent decade, indicating greater clinical significance and scientific interest in PRRT. Original research papers dominate the literature, accounting for more than half of all publications, and the authorship pattern reflects a strong collaborative environment, with multi-authored works being the majority. Journal of Nuclear Medicine acts as an important dissemination platform. The United States remains the most prolific nation, followed by Germany and Italy. Erasmus University Rotterdam and Erasmus MC are leading the institutional contributions. These results highlight PRRT as a diverse, internationally coordinated research area gaining traction in both academic and clinical contexts.